Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
Young Mo Kang, Young-Eun Park, Won Park, Jung-Yoon Choe, Chul-Soo Cho, Seung-Cheol Shim, Sang Cheol Bae, Chang-Hee Suh, Hoon-Suk Cha, Eun Mi Koh, Yeong-Wook Song, Bin Yoo, Shin-Seok Lee, Min-Chan Park, Sang-Heon Lee, Catherine Arendt, Willem Koetse, Soo-Kon Lee
Korean J Intern Med. 2018;33(6):1224-1233. Published online 2018 Jan 5 DOI: https://doi.org/10.3904/kjim.2016.213
Citations to this article as recorded by 
Risk of tuberculosis disease in patients receiving TNF-α antagonist therapy: A meta-analysis of randomized controlled trials
Fatemeh Khelghati, Mohammad Rahmanian, Elaheh Eghbal, Zahra Sadat Seghatoleslami, Mehdi Goudarzi, Aliasghar Keramatinia, Catherine WM. Ong, Delia Goletti, Lia D'Ambrosio, Rosella Centis, Mohammad Javad Nasiri, Giovanni Battista Migliori
New Microbes and New Infections.2024; 62: 101533. CrossRef
Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment
Yan Luo, Konstantina Chalkou, Satoshi Funada, Georgia Salanti, Toshi A. Furukawa
JAMA Network Open.2023; 6(6): e2321398. CrossRef
Comparative Efficacy of bDMARDs and tsDMARDs for the Treatment of Rheumatoid arthritis: A Systematic Review and Network Meta-Analysis
Penghua Shi, Li Wang, Jiafang He, Yun Lu
International Journal of Biology and Life Sciences.2023; 3(1): 35. CrossRef
The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis
Bei He, Yun Li, Wen-wen Luo, Xuan Cheng, Huai-rong Xiang, Qi-zhi Zhang, Jie He, Wen-xing Peng
Frontiers in Immunology.2022;[Epub] CrossRef
Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection
S. Jayashree, K. Nirekshana, Gunjan Guha, Dipita Bhakta-Guha
Biomedicine & Pharmacotherapy.2018; 102: 894. CrossRef